HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

loxiglumide

cholecystokinin receptor antagonist; RN refers to (+-)-isomer; structure in first source
Also Known As:
4-(3,4-dichlorobenzoylamino)-5-(N-3-methoxypropylpentylamino)-5-oxopentanoic acid; CR 1505; CR-1505
Networked: 56 relevant articles (6 outcomes, 8 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. D'Amato, M: 2 articles (08/2003 - 11/2002)
2. Takeuchi, Tadashi: 2 articles (01/2003 - 07/2002)
3. Shiratori, Keiko: 2 articles (01/2003 - 07/2002)
4. Konturek, S J: 2 articles (06/2002 - 03/2001)
5. Kanemitsu, Daisuke: 1 article (03/2006)
6. Motoyoshi, Tomoko: 1 article (03/2006)
7. Sakagami, Junichi: 1 article (03/2006)
8. Kataoka, Keisho: 1 article (03/2006)
9. Nakajima, Tomoki: 1 article (03/2006)
10. Quaglia, M G: 1 article (10/2004)

Related Diseases

1. Pancreatitis
2. Pancreatic Neoplasms (Pancreatic Cancer)
3. Chronic Pancreatitis
4. Colic (Abdominal Cramps)
5. Gallstones (Gallstone)

Related Drugs and Biologics

1. Cholecystokinin A Receptor
2. Amylases
3. Cholecystokinin Receptors (Cholecystokinin Receptor)
4. Caerulein (Ceruletide)
5. Taurocholic Acid (Sodium Taurocholate)
6. Gastrins
7. Somatostatin (Somatotropin Release-Inhibiting Factor)
8. Cholecystokinin (Pancreozymin)
9. Soybean Oil
10. Pancreatic Polypeptide (Pancreatic Polypeptide (PP))

Related Therapies and Procedures

1. Oral Administration
2. Subcutaneous Infusions
3. Subcutaneous Injections
4. Ligation
5. Injections